Sitagliptin Improved Glycemic Control and Was Well Tolerated When Added to Voglibose Monotherapy in Patients with Type 2 Diabetes

被引：0
|
作者：
Tajima, Naoko
Kadowaki, Takashi
Suzuki, Hideyo
Sato, Asako
Okuyama, Kotoba
Minamide, Toshiomi
Arjona Ferreira, Juan Camilo
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A157 / A157
页数：1
相关论文
共 50 条
  • [1] Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes
    Tajima, Naoko
    Kadowaki, Takashi
    Okamoto, Taro
    Sato, Asako
    Okuyama, Kotoba
    Minamide, Toshiomi
    Ferreira, Juan Camilo Arjona
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (06) : 595 - 604
  • [2] Addition of Sitagliptin Improved Glycemic Control and Was Well Tolerated in Japanese Patients with Type 2 Diabetes on Glinides Monotherapy
    Tajima, Naoko
    Kadowaki, Takashi
    Odawara, Masato
    Minamide, Toshiomi
    Seki, Akiteru
    Oki, Kaori
    Narita, Hirohisa
    Gantz, Ira
    [J]. DIABETES, 2014, 63 : A268 - A268
  • [3] Sitagliptin added to ongoing treatment with pioglitazone improved glycemic control and was well tolerated in Japanese patients with type 2 diabetes (T2DM)
    Kashiwagi, Atsunori
    Tajima, Naoko
    Kadowaki, Takashi
    Nonaka, Kenji
    Moto, Tarooka
    Okuyama, Kotoba
    Nishii, Mikio
    Stein, Peter R.
    [J]. DIABETES, 2008, 57 : A590 - A590
  • [4] Sitagliptin added to ongoing treatment with glimepiride improved glycemic control and was well tolerated in Japanese patients with type 2 diabetes (T2DM)
    Tajima, Naoko
    Kadowaki, Takashi
    Odawara, Masato
    Nishii, Mikio
    Nonaka, Kenji
    Stein, Peter P.
    [J]. DIABETES, 2008, 57 : A589 - A589
  • [5] Sitagliptin added to ongoing treatment with metformin improved glycemic control and was well tolerated in Japanese patients with type 2 diabetes (T2DM)
    Kadowaki, Takashi
    Tajima, Naoko
    Odawara, Masato
    Nishii, Mikio
    Nonaka, Kenji
    Stein, Peter P.
    [J]. DIABETES, 2008, 57 : A589 - A590
  • [6] Once-daily sitagliptin monotherapy provides effective glycemic control over 54 weeks and is well tolerated in patients with type 2 diabetes
    Aschner, Pablo
    Lunceford, Jared
    Williams-Herman, Debora
    [J]. DIABETES, 2007, 56 : A553 - A553
  • [7] Sitagliptin Monotherapy improved glycaemic control in patients with type 2 diabetes
    Aschner, P.
    Kipnes, M.
    Lunceford, J.
    Sanchez, M.
    Mickel, C.
    Davies, M. J.
    Williams-Herman, D.
    [J]. DIABETOLOGIA, 2006, 49 : 5 - 5
  • [8] Addition of Sitagliptin, an Oral, Highly-Selective Dipeptidyl Peptidase-4 Inhibitor, Improved Glycemic Control and Was Well Tolerated in Japanese Patients with Type 2 Diabetes on Insulin Monotherapy
    Kadowaki, Takashi
    Tajima, Naoko
    Odawara, Masato
    Minamide, Toshiomi
    Kawashima, Masaru
    Yanagida, Daisuke
    Taniguchi, Tadaaki
    Ferreira, Juan Camilo Arjona
    [J]. DIABETES, 2011, 60 : A279 - A280
  • [9] ACHIEVEMENT OF GLYCEMIC CONTROL BY SITAGLIPTIN, IN PATIENTS WITH NOT WELL REGULATED TYPE 2 DIABETES
    Paschalidou, E.
    Efthimiadis, I.
    Milioni, V.
    Pavlidou, S.
    Vlachopoulou, M.
    Efthimiadis, A.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [10] Linagliptin Provides Superior Glycemic Control Compared to Voglibose as Monotherapy in Japanese Patients with Type 2 Diabetes
    Kawamori, Ryuzo
    Inagaki, Nobuya
    Araki, Eiichi
    Watada, Hirotaka
    Hayashi, Naoyuki
    Horie, Yoshiharu
    Sarashina, Akiko
    Woerle, Hans-Juergen
    Dugi, Klaus
    [J]. DIABETES, 2010, 59 : A172 - A173
12345